Rosacea Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
TARS | D | Tarsus Pharmaceuticals, Inc. | 5.01 | |
VYNE | F | VYNE Therapeutics Inc. | 1.10 | |
ALDX | F | Aldeyra Therapeutics, Inc. | -1.54 | |
DRMA | F | Dermata Therapeutics, Inc. | 0.00 | |
CUTR | F | Cutera, Inc. | -4.44 |
Related Industries: Biotechnology Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XPH | D | SPDR S&P Pharmaceuticals ETF | 1.85 | |
PILL | F | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 1.4 | |
BBP | C | BioShares Biotechnology Products Fund | 1.21 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 0.87 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.31 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jun 28 | CUTR | Why Are Hedge Funds Shorting Cutera, Inc. (CUTR)? |
- Rosacea
Rosacea is a long-term skin condition that typically affects the face. It results in redness, pimples, swelling, and small and superficial dilated blood vessels. Often the nose, cheeks, forehead, and chin are most involved. A red enlarged nose may occur in severe disease, a condition known as rhinophyma.The cause of rosacea is unknown. Risk factors are believed to include a family history of the condition. Factors that may potentially worsen the condition include heat, exercise, sunlight, cold, spicy food, alcohol, menopause, psychological stress, or steroid cream on the face. Diagnosis is based on symptoms.While not curable, treatment usually improves symptoms. Treatment is typically with metronidazole, doxycycline, or tetracycline. When the eyes are affected azithromycin eye drops may help. Other treatments with tentative benefit include brimonidine cream, ivermectin cream, and isotretinoin. Dermabrasion or laser surgery may also be used. The use of sunscreen is typically recommended.Rosacea affects somewhere between one and ten percent of people. Those affected are most often 30 to 50 years old and female. Caucasians are more frequently affected. The condition was described in The Canterbury Tales in the 1300s, and possibly as early as the 200s BCE by Theocritus.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles